Back to Schemes

MT-RNR1 POCT

Product Code: POCT MT-RNR1 25

From £1300.00

Registration closed: 07/07/2025

Applicable to all labs undertaking point-of-care molecular testing of MT-RNR1 for avoidance of aminoglyocside induced hearling loss in neonates.

Target/Genes:

The MT-RNR1 m.1555A>G variant associated with aminoglycoside induced hearing loss in neonates 

Technology:

PCR based

Language:

Not applicable

Sample Type:

Artificial Buccal Swab

Accredited:

No

EQA Assessment

The scheme is designed to assess the analytical process (genotyping) only.

Sample Details

Artificial Buccal swabs created by coating swabs with fixed cells from patient-derived lymphoblastoid cell lines and contain varying cell loads designed to mimic real patient samples.
 
The material is not expected to contain any infectious agents but the samples should be handled with the same caution as for clinical specimens.

EQA Results

The user will receive will a survey report containing device specific performance data benchmarked against the cohort of participating users. Additionally a annual report summarising the years data will be provided.

Participation Information

Users will receive three EQA samples every two months (18 samples per year), allowing them to verify the ongoing accuracy of MT-RNR1 testing on their POCT devices, to ensure patients receive the most reliable diagnoses possible. 
 
No restrictions on number of participants. Open to laboratories from ALL countries (note: some restrictions may apply*)

*Sanctions, delivery network exceptions, restrictions on importation etc.

How it works

Register

  • Enrol before the closing date
  • EMQN ships EQA samples or digital cases

Test & submit results

  • Analyse samples in your routine workflow
  • Upload results via QA Manager

Review & get certified

  • EMQN benchmarks your data
  • Receive final report & Certificate of Participation

Enquire about this scheme

Contact Information

added wishlist!
View Wishlist

0

View Wishlist

Register Interest

Express your interest in ''.